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Frailty: from clinical syndrome to epidemiological construct?
More people now live to advanced ages. The health and 
social care needs of the growing population with age-
related frailty are becoming important public health 
and health policy concerns. Frailty has been described as 
”a distinctive health state related to the ageing process 
in which multiple body systems gradually lose their in-
built reserves,”1 rendering frail individuals susceptible 
to adverse outcomes such as falls, fractures, hospital 
admissions, and mortality. The notion of frailty has 
potential for risk stratification, but how can it be defined 
and recognised and what are the causes of frailty? 
 A qualitative study,2 published earlier this year, found 
that physicians can generally recognise frailty when 
they see it in their patients but clinicians acknowledge 
uncertainty and lack of reliability in classifying their 
patients’ frailty status in the absence of clear definitions 
and diagnostic criteria. Many researchers have tried to 
operationalise definitions of frailty, of which the most 
widely accepted is the frailty phenotype proposed by 
Fried and colleagues.3 This model is based on the co-
occurrence of at least three of five apparently non-
specific features including unintentional weight loss, 
self-reported exhaustion, weakness (low grip strength), 
slow walking speed, and low physical activity.3 Another 
approach to the classification of frailty draws on the 
cumulative deficit model leading to the calculation of a 
quantitative frailty index. The Frailty Index developed 
by Rockwood and colleagues.4 considers the number 
of possible deficits in an individual. Recent exemplars 
of this approach include the e-Frailty Index5 and the 
Hospital Frailty Risk Score.6 The construction of these 
indices shows considerable overlap with the concept of 
multiple morbidity.7 Frailty indices are generally strongly 
associated with mortality5 and this finding suggests that 
some patients with frailty might be approaching a stage 
of terminal decline.8 
Two papers, one by Eric Brunner and colleagues9 and 
the other by Peter Hanlon and colleagues,10 in this issue 
of The Lancet Public Health, explore the epidemiology 
of frailty in the context of two well-known UK cohort 
studies, the Whitehall II and UK Biobank studies, 
respectively. Both reports assessed relatively young 
populations. The Whitehall II study assessed participants 
at a mean age of 69 years, with a minority of women, 
whereas the analysis of UK Biobank study included 
participants aged 37–73 years. Both reports used Fried’s 
phenotype to assess frailty, classifying participants as 
pre-frail if they showed one or two features, and frail if 
they showed three or more. In the Whitehall II study,9 
fewer than 2% showed evidence of frailty under the age 
of 65, increasing to more than 10% at 75 years or older. 
There were substantial inequalities in the occurrence 
of frailty, which was more frequent in women, ethnic 
minority groups and those with low employment grade. 
Low employment grade at age 50 years was associated 
with 2·60 times higher odds  of later frailty (95% CI 
1·89–3·58). Participants who had long-term conditions 
or lifestyle risk factors for long-term conditions at the 
age of 50 years were more likely to develop frailty in 
later life, and these characteristics largely accounted for 
inequalities in frailty. These findings are consistent with 
those of a recent international study,11 which explored 
inequalities in walking speed in old age and support the 
view that social inequality has a major negative effect on 
healthy ageing.12
In the UK Biobank study,10 16 538 (3%) of 
493 737 participants met the criteria for frailty, with more 
than a third of the sample (185 360 [38%] of 493 737) 
meeting the criteria for pre-frailty. Multiple morbidity 
was strongly associated with frailty in the UK Biobank 
data with participants with four or more long term 
conditions having 27 times higher odds of frailty than 
those with no long-term conditions (OR 27·1, 95% CI 
25·3–29·1). Of all individual long-term conditions, frailty 
was most frequently observed in patients with multiple 
sclerosis and chronic fatigue syndrome. Obesity at midlife 
was associated with frailty in both studies, suggesting 
that targeting modifiable risk factors at midlife might 
reduce the occurrence of frailty at later ages.
These new analyses advance our understanding 
of the association between long-term conditions, 
multiple morbidity, and frailty. These studies show that 
long-term conditions and their risk factors are often 
antecedents of frailty; multiple morbidity and frailty 
often co-exist. The data also raise questions concerning 
our present epidemiological definitions of frailty. The 
high proportion of participants classified as pre-frail in 
the UK Biobank study could suggest that the definition 
lacks specificity; however, pre-frailty was associated with 
mortality in the UK Biobank data with hazard ratios for 
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mortality at age 65–73 years compared with the non-
frail group of 1·45 in men (95% CI 1·34–1·57) and 1·50 in 
women (1·34–1·68). Other recent studies have assessed 
the associations of low walking speed11 or low grip 
strength13 with mortality without invoking the concept 
of frailty. There is a lack of consensus on the definition 
of frailty; the classification of individuals as frail depends 
on the theoretical construct incorporated in the frailty 
model,14 raising a possibility that there might be more 
than one kind of frailty. At present, the term frailty 
might be viewed as describing one phase of an ageing 
continuum and this continuum is perhaps not readily 
dichotomised.
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